Trans Genic INC. japanese
Corporate Information
News Releases
Products & Service
Investor Relations
Career
What's New
2006

Dec.20
press release Notice of Conclusion of Agency Agreement with TriStar Technology Group, LLC. (USA)
Dec.15
press release Regarding Patent for GANP® Genes Granted in the U.S.
Nov.20
press release Notice of Conclusion of License Agreement for High-affinity Antibody Technology using GANP Mouse
Nov. 1
press release Improvement of R&D Functions of Kobe Research Center
Oct.30
press release TRANS GENIC's subject was selected for “ Collaborative Development of InnovativeSeeds, Potentiality Verification Stage ” of JST
Oct.27
products Product Launch 4 antibodies
Oct.16
press release Notice of Introduction of New Antibody-Producing Technology (DNA Immunization) and Launch of the Related Business
Oct. 2
press release Launch of Contract Research based on Agreement with JST
Sep.21
press release Notice of Launching "TG Resource Bank" Business
Sep.20
press release Agreement Concluded on Business Tie-up between genOway and TRANS GENIC
Jul.31
products We released a list of gene knockout embryonic stem cells (ES cells) and renewed our mouse strain list adding a wide range of new strains.
Jul.13
press release Notice of Conclusion of License Agreement for “Anti-HIV antibody”
Jun.30
  Update Information:To Our Shareholders
Jun.29
press release Acquisition of Patent on Assay System for Cancer Diagnosis Using Urine Samples .
Jun.21
products Mouse Strain List has been updated with 33 additional mice strains(T0185-T0217)
May.15
press release Primmune K. K. becomes a subsidiary of TRANS GENIC INC.
May.15
press release Notice of Partial Amendment to Articles of Incorporation
May.15
press release Notice of Reverse Split of Shares
May.15
press release Notice of Reduction of Capital Reserve.
May.10
press release Notice of Earnings Forecast for Fiscal Year Ending March 31, 2006
Apr.24
press release High-affinity Antibody Technology using GANP Mouse: The Development of In Vitro Diagnostic Products
Apr.4
products Product Launch 7 antibodies
Mar.20
press release Notice on Completion of Early Redemption and Cancellation of Unsecured Convertible Bonds with Stock Acquisition Rights and Stock Acquisition Rights issued by TRANS GENIC INC .
Mar.2
  Update Information: List of Antibody Products
Feb.17
press release TRANS GENIC and Livedoor Group Agree on Dissolution of Comprehensive Business Tie-up Regarding Bio-related Business.
Feb.17
press release Early Redemption and Cancellation of Convertible Bonds with Stock Acquisition Rights and Stock Acquisition Rights, and Dissolution of Management and Advisory Agreement with Livedoor Securities Co., Ltd.
Feb.13
products - Conclusion of agreement on business tie-up with JSW-Research -
Having commenced marketing activities based on this agreement, service contents of JSW-Research are now available on our web site.
 
 
>>2010
>>2009
>>2008
>>2007
>>2006
>>
2005
>>
2004
Contact UsTerms of UseSite MapWhat's New